Surging Popularity of Lightweight Vehicles Driving Aluminum Adoption in Automotive Industry

With the burgeoning requirement for greater fuel efficiency, many automobile manufacturers are focusing on developing lightweight vehicles. Additionally, lightweight automobiles have better braking and acceleration and are easier to handle than heavier vehicles. Moreover, the weight of the amount of aluminum needed for providing the same strength as that of steel is 40% lesser than steel. Furthermore, the implementation of stringent emission regulations in several countries is also pushing up the requirement for lightweight vehicles, as these vehicles generate lower emissions. This is, in turn, driving the demand for aluminum in the automotive industry. 

Besides, 90% of the aluminum used in vehicles can be easily recycled. Owing to these factors, the global automotive aluminum market is exhibiting huge expansion. Currently, the industry is highly fragmented, with the presence of a large number of small organizations such as Alcoa Corporation, Norsk Hydro ASA, Aluminum Corporation of China Limited (Chalco), Aleris International Inc., Constellium NV, Rio Tinto plc, Novelis Inc., Kaiser Aluminum Corporation, and United Company RUSAL plc. However, in the coming years, the industry will witness the entry of several new firms that will develop innovative and advanced products. 

Automotive Aluminum Market

Aluminum is used in the manufacturing of light commercial vehicles (LCVs), heavy commercial vehicles (HCVs), and passenger cars. Out of these, the usage of aluminum is predicted to be the highest in passenger cars in the coming years. This will be because of large-scale manufacturing of passenger cars, particularly in China and India, and the soaring requirement for fuel-efficient vehicles. Extrude aluminum, rolled aluminum, and cast aluminum are the major types of aluminum used in automobiles. 

This will be because of the surging demand for lightweight cars across the world. Globally, Asia-Pacific generated the highest revenue in the automotive aluminum market in the years gone by and this trend is predicted to continue in the coming years as well. This will be because of the extensive manufacturing of passenger cars in several regional countries such as India and China and the soaring investments being made by automobile manufacturing companies for the manufacturing of automobiles in the region.

Thus, it can be said without hesitation that the demand for aluminum will surge sharply in the automotive industry in the coming years, primarily because of the soaring requirement for lightweight vehicles, on account of their greater fuel efficiency and easier handling, and the increasing implementation of stringent emission regulations by the governments of several countries in order to mitigate vehicular emissions. 

Read More

Why are Sales of Botanical Supplements Surging Globally?

Botanical supplements refer to the dietary supplements produced from plants or parts of plants for therapeutic and medical purposes. The products made from botanicals are used for the management and prevention of several ailments and diseases and are also known as photomedicine. These supplements work as natural alternatives for hormone replacement therapies, as plants have played a major role in various treatment procedures for thousands of years. These supplements also provide natural ways to improve brain health, cognitive function, and prostate health and joint and connective tissue health. 

In recent years, the sales of these supplements have surged sharply, primarily because of the increasing health consciousness of people, rising concerns toward diet, and improved care toward preventive healthcare. Moreover, many botanical supplement producers have launched alternative therapies for relieving women from issues, such as insomnia and hot flashes menopause. Middle-aged women and geriatric people are the primary end users of botanical therapies and supplements. Natural products, such as probiotic drinks and detoxes, cranberry and herbal supplements, and fish oils are quickly becoming very popular botanical supplements across the world. 

These supplements are also classified, depending on formulation, into powders, syrups, capsules, oils, and frizzing tablets. Baby boomers, adult women, and adult men are the major end users of these supplements, while cosmetics, food and beverages, pharmaceuticals, animal feed, and agriculture are the major application areas of these supplements. Geographically, the demand for these supplements was found to be the highest in Europe during the last few years. Currently, Asia-Pacific (APAC) is quickly becoming a major region for the players operating in the botanical supplements market for potential expansion. 

This is credited to the increasing disposable income of the middle-class populace and the long-standing tradition of botanical medicine in regional countries, such as China, India, and Thailand. Natures Sunshine Products Incorporated, NaturaLife Asia Co., Proctor & Gamble, Imperial Ginseng Products Ltd., Pharmaton Natural Health Products, The Himalaya Drug Company, International Vitamin Corp., Arizona Natural Resources, Inc., and Nutraceutical International Corporation are some of the major botanical supplement producing companies all over the world. 

Hence, it can be said without any hesitation that the demand for botanical supplements will surge sharply in the coming years, mainly because of the growing health consciousness of people and their rising disposable income, the soaring incidence of chronic diseases, mushrooming requirement for natural alternatives to conventional medicines, and ballooning population of geriatric people across the world. 

Read More

How Are Technological Developments Improving Oligonucleotides?

 A surge in research activities in synthetic biology and improvement in oligonucleotide synthesis have led to the development of advanced oligonucleotides. Recent innovations in synthesis techniques have led to the swift and cost-effective synthesis of oligomers. Moreover, the developments of novel sets of protecting amino groups, better coupling reagents, and high-throughput synthesizers have transformed the synthesis of oligonucleotides. These advancements will propel the oligonucleotide synthesis market at 10.8% CAGR during 2018–2023. At this rate, the market is expected to reach $2.8 billion by 2023 from $1.5 billion in 2017.

Read the full report - Oligonucleotide Synthesis Market Size and Demand Forecast 

In the same vein, the evolution of microarray technology has assisted the development of oligonucleotide products for therapeutic and diagnostic processes. For example, research of numerous oligonucleotides with biological ligands has led to its increased application in the diagnosis of several inherited disorders. Similarly, constant improvement in microchip-based oligonucleotide synthesis has led to the surge in throughput and decrease in cost of synthesis of oligonucleotides. Additionally, developments in technologies, such as enzymatic error correction, have led to the reduction in frequency of errors in synthesized products.

Apart from this, academic research institutes, food and beverage companies, diagnostic laboratories, forensic laboratories, and pharmaceutical and biotechnology companies use oligonucleotides for various applications. Among these end users, the diagnostic laboratories use the highest volume of oligonucleotides for diagnostic purposes, on account of their increasing applications in molecular diagnosis of inherited disorders. Besides, the academic research institutes also use these products in large quantities as probes in antisense analyses, microarray, and in-situ hybridization.

Due to widening application base, market players are focusing on improving and expanding their product portfolios. For instances, Thermo Fisher Scientific Inc., in October 2017, launched Applied Biosystems Axiom Africa Array for commercial purposes. The product was introduced for medical and population genomics to support and accelerate global health research. Thermo Fisher Scientific Inc. and The Wellcome Trust Sanger Institute combined their respective expertise in informatics and human genomic analysis to co-develop Applied Biosystems Axiom Africa Array that assists in capturing genome variation in the European, African, and Asian populace.

Thus, the continuous advancements in technologies coupled with high prevalence of life-threatening diseases that demand early diagnosis and treatment will fuel the adoption of oligonucleotides in the coming years. 

Read More

How are Government Initiatives Propelling North American Defibrillators Market?

 One in every four deaths, i.e. 647,000 deaths in the U.S., are a result of cardiovascular diseases (CVD), according to the Centers for Disease Control and Prevention (CDC). If the heart is still beating, but in an arrhythmic pattern, a defibrillator is used to treat it. The device sends an electric shock, which neutralizes a large amount of the current coming from the heart’s natural pacemaker, to allow the sinoatrial node to resume its normal functioning. Arrhythmias can be fatal if not stopped immediately, especially ventricular fibrillation (v-fib), during which the body has no pulse

These devices come in two variants: external defibrillators and implantable cardioverter defibrillators (ICD). External ones are commonly seen at hospitals and operated by medical professionals, while ICDs are implanted inside the body, for regular cardiac care. Of these, ICDs have witnessed higher uptake, on account of the technological advancements in these instruments and rising incidence of sudden cardiac arrest (SCA). In the coming years, the external variants are predicted to witness a more rapidly increasing uptake.

Browse report overview and detailed TOC at North American Defibrillators Market Demand Forecast Report

A key trend in the region is itself the rising adoption of automated external defibrillators (AED). The government, at the national and state/province levels, is taking initiatives to install public-access defibrillators (PAD), which are mostly AEDs, for the use of general public, in situations of emergency. Areas which witness a high footfall, such as schools and colleges, train stations, airports, shopping centers, leisure centers, and malls, are being rapidly equipped with AEDs, so that if anyone suffers a heart issue, bystanders can use the device to restore their sinus rhythm, until medical help arrives.

The surging geriatric population in many North American countries is one of the major factors responsible for the growth of the North American defibrillators market. In North America, the population of geriatric people is growing at the fastest rate in the U.S. As per the report published by the Population Reference Bureau in 2018, the total number of people in the age bracket (65 years and above) in the U.S. is predicted to rise from 46 million to more than 98 million during 2014—2060. 

Hence, as people realize the importance of defibrillators, and governments keep up their efforts to make them easily accessible to the public, their uptake in North America will keep rising.

Read More

Increasing Prevalence of Benign Prostatic Hyperplasia in American Men Driving Demand for BPH Treatment Procedures

Benign Prostatic Hyperplasia (BPH) is a medical condition in which the prostate gland becomes enlarged. The enlargement of the prostate gland causes urinary tract problems by blocking the flow of urine out of the body. This happens because the prostate gland surrounds the urethra, which is the tube that carries the urine from the urinary bladder to out of the body, and so, the enlargement of the gland squeezes or blocks the urethra, causing discomfort and problems while urinating. 

Browse detailed report with COVID-19 impact analysis at BPH Procedures Research Report

This condition is common in geriatric men, so much so, that almost half of all men in the age bracket 51—60 years suffer from it. As per many studies and reports, up to 90% of all men over the age of 80 years all over the world suffer from benign prostatic hyperplasia. This disease is commonly treated via medications, laser-based treatment, transurethral resection of the prostate (TURP), and various other energy-based treatments such as prostate artery embolization and implants.

Out of the surgical, laser-based, and UroLift procedures, the requirement for UroLift treatment procedures is predicted to rise rapidly in the U.S. in the forthcoming years. The main factors responsible for the growing popularity of these treatment procedures are the increasing aging population, lower-costs of the procedure in comparison to the other energy-based procedures, and increasing provision of insurance coverage for this procedure by many insurance companies in the country.

Out of these, the demand for green light laser-based procedures was observed to be significantly high in the U.S. during the last few years. According to many experts, the main factor responsible for the large-scale adoption of green light laser-based procedures was the fact that these procedures allow faster recovery and cause far lesser short-term side effects in comparison to the other laser-based procedures. Moreover, these procedures significantly improve the comfort level experienced by patients while urinating.

Therefore, it can be said with complete certainty that the demand for benign prostatic hyperplasia treatment (BPH) procedures will rise enormously in the U.S. in the upcoming years, because of the growing prevalence of BPH in males and the rapid advancements and innovations being made in these procedures in the country.

Read More

Automotive Industry Installing Safety Systems to Mitigate Road Accidents

The World Health Organization (WHO) estimates that nearly 1.3 million human lives are lost due to road traffic crashes worldwide. To reduce the incidences of road accidents and related deaths, the WHO has initiated a package of six strategies — Save LIVES. The components of this initiative are speed management, leadership, infrastructure design, vehicle safety standards, enforcement of traffic laws, and survival after a crash. The vehicle safety standards of this initiative mandate the installation of seat belts, child restraint anchorage points, anti-lock braking devices, and electronic stability control.

Thus, the increasing global concerns regarding the high prevalence of road accident fatalities will help the automotive safety system market prosper during 2020–2030. Apart from the international organizations, governments of various countries are also mandating the incorporation of vehicle safety features in passenger cars and commercial vehicles to reduce road accident cases. In the coming years, the burgeoning demand for passenger cars, especially luxury cars, owing to the mounting disposable income of people, will create a huge requirement for vehicle safety features worldwide.

Automotive Safety System Market

Active and passive safety systems being integrated into conventional and autonomous vehicles are offered by Robert Bosch GmbH, BYD Auto Co. Ltd., BorgWarner Inc., Continental AG, Bayerische Motoren Werke (BMW) AG, Magna International Inc., DENSO Corp., and Infineon Technologies AG. These companies are engaged in the development of hardware and software of the vehicle safety systems. In the upcoming years, they will be involved in the largescale development and distribution of safety software, owing to the surging adoption of automotive internet of things (IoT) solutions, advanced driver assistance systems (ADAS), connected vehicle technology, and vehicle telematics in the automotive industry. 

According to P&S Intelligence, North America led the automotive safety system market in the preceding years, due to the implementation of stringent vehicle safety regulations in the U.S. and Canada. For instance, the National Highway Traffic Safety Administration (NHTSA) issues Federal Motor Vehicle Safety Standards (FMVSS) to implement vehicle safety laws from the U.S. Congress. These laws enable the U.S. Department of Transportation (DoT) to achieve its mission to reduce and prevent vehicle crashes. 

Thus, the escalating need to reduce road accident cases and the increasing implementation of vehicle safety regulations will encourage the integration of safety systems in automobiles.  

Read More

Burgeoning Vehicle Production Propelling Automotive Transmission System Demand

The International Organization of Motor Vehicle Manufacturers (OICA) estimates that 77,621,582 vehicles were produced globally in 2020, of which 21,787,126 units were commercial vehicles and 55,834,456 units were cars. Thus, the burgeoning production and sales of vehicles, especially in the Asia-Pacific (APAC) and North American regions, is projected to fuel the integration of automotive transmission systems in vehicles in the near future.

Moreover, the rapid technological advancements and the surging disposable income of people in developing countries will also help the automotive transmission market prosper in the forthcoming years. For instance, the Reserve Bank of India (RBI) data reveals that the gross national disposable income and net national disposable income of India grew from INR 1,92,62,652 crore in the financial year (FY) 2018–2019 to INR 2,06,30,319 crore in the FY 2019–2020 and INR 1,72,83,028 crore in the FY 2018–2019 to INR 1,85,11,719 crore in the FY 2019–2020, respectively.

Automotive Transmission Market Report

The leading manufacturers of manual transmission systems and automatic transmission systems, such as dual-clutch transmission (DCT), automated manual transmission (AMT), and continuously variable transmission (CVT), include DENSO Corporation, Faurecia S.A., TRW Automotive Holdings Corp., Hitachi Automotive Systems, Continental AG, Hyundai Mobis Co. Ltd, Robert Bosch GmbH, ZF Friedrichshafen AG, BASF SE, Aisin Seiki Co. Ltd., Yazaki Corp., Sumitomo Electric Industries, Johnson Controls Inc., Lear Corp., Toyota Boshoku Corp., Magna International Inc., Delphi Automotive PLC, and JTEKT Corp.

According to P&S Intelligence, the APAC region leads the automotive transmission market, wherein China is the leading user of automotive transmission systems. The dominance of China can be attributed to the largescale automobile production and extensive demand for personal vehicles. The OICA states that China manufactured 5,231,161 commercial vehicles and 19,994,081 cars in 2020. Additionally, the mounting disposable income and accelerating urbanization in India and Thailand will also facilitate the adoption of automotive transmission systems in the region. 

Thus, the soaring automobile sale and production and the growing customer preference for enhanced comfort and smooth driving options will augment the usage of automotive transmission systems in the upcoming years.  

Read More